Maine recalls

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Complaints of the ceramic tip of the resection sheath breaking have been received.

Product being removed due to incompatibility when used in conjunction with a GreenLight Laser for BPH therapy which could damage the tip of the device.

Due to battery component overheating while charging resulting in melting of internal components and causing smoke.

Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.

Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.

Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.

Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.

Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for sterile products.

Downstream recall. Product contains arrowroot flour ingredient that was voluntarily recalled by the supplier due to potential contamination of soft kraft paper/plastic bag pieces.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.

Product Contamination